SAS for Clinical Research & BFSI: What It Is, Who Can Do It, and How to Build a Career

Why SAS Still Matters

SAS remains the industry workhorse where accuracy, auditability, and regulatory compliance are non-negotiable—exactly the reality in pharmaceuticals/biotech and in banking/financial services (BFSI). In clinical research, SAS underpins FDA/PMDA-aligned data standards and submissions; in BFSI, it powers risk, stress testing, fraud/AML, and IFRS 9 expected-credit-loss (ECL) modeling at scale.

What SAS Does in Clinical Research (Pharma, Biotech, CROs)

Core Responsibilities

• Build compliant data pipelines: Raw trial data → SDTM domains → ADaM analysis datasets → TLFs (tables, listings, figures) for regulators.

• Produce submission-ready deliverables (define.xml, annotated CRFs, TLF packages) and maintain traceability from result → ADaM → SDTM.

• Work within quality frameworks (QC/double programming), audit trails, and 21 CFR Part 11 controls for electronic records/signatures.

Why Standards Matter

• FDA’s Study Data Standards framework and catalog set expectations for format/structure of study data in NDAs/BLAs/ANDAs.

• SDTM/ADaM implementation guides (SDTMIG, ADaMIG) define how sponsors should organize variables and structures.

Daily Toolset

• Base SAS, SAS/STAT, SAS/GRAPH/ODS, PROC REPORT/TABULATE, Macro/SQL for automation and reproducibility.

What SAS Does in BFSI (Banks, Insurers, Fintech)

Core Responsibilities

• Regulatory Stress Testing & Capital Planning: Build, validate, and document models used in CCAR/DFAST exercises under the Fed’s rules.

• Model Risk Management (MRM): Establish governance, development, validation, and monitoring practices per SR 11-7.

• Credit Risk & IFRS 9 ECL: Estimate PD/LGD/EAD, stage assets, and generate disclosures under IFRS 9’s forward-looking ECL regime.

• Fraud/AML: Transaction monitoring, network analytics, case management, and regulatory reporting leveraging SAS AML and financial-crime analytics.

Daily Toolset

• Base SAS, SAS/STAT, high-performance procedures; scorecards; macro automation; model governance documentation aligned to SR 11-7.

Who Can Do SAS in These Domains?

Clinical Research

• Education: Pharmacy, Life Sciences, Biotechnology, Medicine, Nursing, Public Health, Biostatistics, Statistics, Computer Science.

• Strengths: Statistical thinking, attention to detail, GxP mindset, documentation discipline, familiarity with CDISC, and comfort reading protocols/analysis plans.

• Good to have: Knowledge of 21 CFR Part 11 and eCTD expectations.

BFSI

• Education: Statistics/Mathematics, Economics, Engineering, Finance/Accounting, Data Science/Analytics, MBA (quant), or actuarial background.

• Strengths: Probability, time-series, logistic/linear modeling, survival/credit-risk techniques, and rigorous model validation/reporting aligned to SR 11-7.

Skills Map: What to Learn First

Common Core (Both Domains)

• Base SAS (DATA step, PROC SQL), Macro programming, ODS/PROC REPORT, Git-style versioning, documentation hygiene.

Clinical Progression

1. SDTM concepts → 2. ADaM derivations (ADSL, BDS, OCCDS) → 3. TLF automation → 4. Submission artifacts (define.xml) and QC.

BFSI Progression

1. Data quality & feature engineering → 2. PD/LGD/EAD models and benchmarking → 3. ECL staging/reporting per IFRS 9 → 4. MRM & SR 11-7 documentation → 5. CCAR/DFAST narratives and controls.

Mini-Workflows

Clinical Trial Pipeline

1. Import/clean raw CRF/ePRO data

2. Map to SDTM domains (DM, AE, LB, VS, etc.)

3. Derive ADaM datasets (ADSL, ADAE, ADLB, ADVS) with traceability

4. Produce TLFs for endpoints; QC via independent replication

5. Package for submission aligned to FDA study-data standards.

Bank Risk & Compliance Pipeline

1. Aggregate customer/exposure/transaction data

2. Build/validate models (credit risk, stress scenarios, fraud/AML)

3. Generate IFRS 9 ECL and capital-planning outputs

4. Document governance, monitoring plan, challenger models per SR 11-7

5. Submit CCAR/DFAST templates and narratives.

Tools of the Trade

• SAS Risk/IFRS 9 for ECL workflows and disclosures.

• SAS AML/Financial Crimes Analytics for monitoring, graph/network analysis, case management, and reporting.

 Starter Learning Path (6–8 Weeks)

Weeks 1–2: Foundations

• Base SAS + PROC SQL; automation with Macro.

• Read FDA Study Data Standards (clinical) and SR 11-7 summary (BFSI).

Weeks 3–4: Domain Essentials

• Clinical: Build one SDTM domain (DM) and one ADaM (ADSL), then produce a demographics TLF.

• BFSI: Build a small PD model and compute a simple 12-month ECL mockup; write a short methodology memo.

Weeks 5–6: Compliance Mindset

• Clinical: Document traceability and QC; understand Part 11 implications.

• BFSI: Draft model governance artifacts and monitoring plan.

Weeks 7–8: Platform Fluency

• Explore advanced SAS programming techniques and domain-specific solutions (AML, IFRS 9).

 FAQs

Is SAS being replaced by Python/R?
In regulated settings, SAS persists because of its auditability, legacy validation, and deep alignment with standards (CDISC in clinical; SR 11-7/IFRS 9 in banking). Many teams use SAS and Python/R side-by-side.

What Portfolios Help Me Get Hired?

• Clinical: One SDTM + one ADaM build with a small TLF pack, plus QC log.

• BFSI: One PD scorecard with explainability, one ECL roll-forward, and a short SR 11-7-aligned validation memo.

If your goal is clinical trial analytics or financial risk/compliance, SAS gives you a governed, standards-aligned path to production. Learn the base language, master the domain standards (CDISC or SR 11-7/IFRS 9), and then leverage specialized solutions (AML, IFRS 9) to scale your impact.